Connecticut Wealth Management, LLC Amgen Inc Transaction History

Connecticut Wealth Management, LLC

$2.06 Billion
Q3 2024

A detailed history of Connecticut Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Connecticut Wealth Management, LLC holds 2,202 shares of AMGN stock, worth $648,555. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,202

Previous 2,357 6.58%

Holding current value

$648,555

Previous $736,000 3.67%

% of portfolio

0.03%

Previous 0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $47,953 - $52,293	-155 Reduced 6.58%	2,202 $709,000
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $65,687 - $79,827	250 Added 11.87%	2,357 $736,000
Q1 2024 May 01, 2024	BUY	$268.87 - $324.56 $11,561 - $13,956	43 Added 2.08%	2,107 $599,000
Q4 2023 Feb 06, 2024	BUY	$255.7 - $288.46 $76,965 - $86,826	301 Added 17.07%	2,064 $594,000
Q3 2023 Oct 19, 2023	BUY	$218.65 - $271.46 $38,701 - $48,048	177 Added 11.16%	1,763 $473,000
Q2 2023 Jul 25, 2023	BUY	$214.27 - $253.37 $40,925 - $48,393	191 Added 13.69%	1,586 $352,000
Q1 2023 Apr 18, 2023	SELL	$225.79 - $275.2 $12,644 - $15,411	-56 Reduced 3.86%	1,395 $337,000
Q4 2022 Jan 17, 2023	BUY	$229.03 - $291.01 $14,886 - $18,915	65 Added 4.69%	1,451 $0
Q3 2022 Nov 02, 2022	BUY	$224.46 - $253.15 $62,848 - $70,882	280 Added 25.32%	1,386 $312,000
Q2 2022 Jul 12, 2022	SELL	$230.71 - $256.74 $4,614 - $5,134	-20 Reduced 1.78%	1,106 $269,000
Q1 2022 Apr 18, 2022	BUY	$219.27 - $242.57 $4,166 - $4,608	19 Added 1.72%	1,126 $272,000
Q4 2021 Jan 24, 2022	BUY	$198.88 - $227.6 $198 - $227	1 Added 0.09%	1,107 $249,000
Q3 2021 Nov 02, 2021	BUY	$212.27 - $248.7 $6,155 - $7,212	29 Added 2.69%	1,106 $235,000
Q2 2021 Jul 29, 2021	BUY	$233.58 - $259.14 $2,802 - $3,109	12 Added 1.13%	1,077 $263,000
Q1 2021 Apr 29, 2021	SELL	$221.91 - $258.6 $199,719 - $232,740	-900 Reduced 45.8%	1,065 $265,000
Q4 2020 Jan 29, 2021	SELL	$216.38 - $257.67 $9,087 - $10,822	-42 Reduced 2.09%	1,965 $452,000
Q3 2020 Oct 13, 2020	SELL	$234.65 - $260.95 $33,320 - $37,054	-142 Reduced 6.61%	2,007 $510,000
Q2 2020 Jul 14, 2020	BUY	$197.81 - $242.74 $39,759 - $48,790	201 Added 10.32%	2,149 $507,000
Q1 2020 Apr 20, 2020	SELL	$182.24 - $241.7 $8,929 - $11,843	-49 Reduced 2.45%	1,948 $395,000
Q4 2019 Jan 29, 2020	BUY	$189.21 - $243.2 $9,460 - $12,160	50 Added 2.57%	1,997 $482,000
Q3 2019 Oct 24, 2019	BUY	$174.11 - $208.62 $174 - $208	1 Added 0.05%	1,947 $377,000
Q2 2019 Jul 29, 2019	BUY	$166.7 - $195.41 $324,398 - $380,267	1,946 New	1,946 $359,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connecticut Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Connecticut Wealth Management, LLC with notifications on news.

Account

Connecticut Wealth Management, LLC Amgen Inc Transaction History